Ikarian Capital, LLC Spruce Biosciences, Inc. Transaction History
Ikarian Capital, LLC
- $328 Million
- Q2 2025
A detailed history of Ikarian Capital, LLC transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,000,000 shares of SPRB stock, worth $110 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$110 Million
Previous $290,000
75.86%
% of portfolio
0.02%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding SPRB
# of Institutions
6Shares Held
6.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$323 Million20.39% of portfolio
-
Abingworth LLP London, X01.79MShares$197 Million0.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$115 Million0.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$13.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY65Shares$7,1560.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $2.59B
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...